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Abstract
Precise identification of neuronal populations is a major challenge in neuroscience. In the striatum, more than 95% of
neurons are GABAergic medium-sized spiny neurons (MSNs), which form two intermingled populations distinguished by
their projections and protein content. Those expressing dopamine D1-receptors (D1Rs) project preferentially to the
substantia nigra pars reticulata (SNr), whereas those expressing dopamine D2- receptors (D2Rs) project preferentially to the
lateral part of the globus pallidus (LGP). The degree of segregation of these populations has been a continuous subject of
debate, and the recent introduction of bacterial artificial chromosome (BAC) transgenic mice expressing fluorescent
proteins driven by specific promoters was a major progress to facilitate striatal neuron identification. However, the fraction
of MSNs labeled in these mice has been recently called into question, casting doubt on the generality of results obtained
with such approaches. Here, we performed an in-depth quantitative analysis of striatal neurons in drd1a-EGFP and drd2-
EGFP mice. We first quantified neuronal and non-neuronal populations in the striatum, based on nuclear staining with TO-
PRO-3, and immunolabeling for NeuN, DARPP-32 (dopamine- and cAMP-regulated phosphoprotein Mr,32,000), and
various markers for interneurons. TO-PRO-3 staining was sufficient to identify MSNs by their typical nuclear morphology
and, with a good probability, interneuron populations. In drd1a-EGFP/drd2-EGFP double transgenic mice all MSNs expressed
EGFP, which was driven in about half of them by drd1a promoter. Retrograde labeling showed that all MSNs projecting to
the SNr expressed D1R and very few D2R (,1%). In contrast, our results were compatible with the existence of some D1R-
EGFP-expressing fibers giving off terminals in the LGP. Thus, our study shows that nuclear staining is a simple method for
identifying MSNs and other striatal neurons. It also unambiguously confirms the degree of segregation of MSNs in the
mouse striatum and allows the full exploitation of results obtained with BAC-transgenic mice.
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Introduction
Basal ganglia form a complex neural network involved in the
selection and execution of action through interactions with
multiple brain areas that process sensorimotor, emotional and
cognitive information [1]. The striatum is a central component of
the basal ganglia that collects and processes information coming
from the cerebral cortex and the thalamus [2]. Medium-sized
spiny neurons (MSNs) constitute the major cell type, comprising
about 95% of striatal neurons in rodents (see [3]). The remaining
5% of neurons are composed of aspiny interneurons, which have
been classified on the basis of their morphology, protein content
and electrophysiological properties as large cholinergic interneu-
rons and somatostatin-, parvalbumin- and calretinin-expressing
GABAergic interneurons [4].
MSNs receive excitatory glutamatergic inputs from the cerebral
cortex and the thalamus, and a modulatory dopaminergic
innervation from the midbrain. They belong to two intermingled
subpopulations distinguished by their projections and protein
expression patterns. MSNs expressing dopamine D1-receptors
(D1Rs), dynorphin and substance P, project to the substantia nigra
pars reticulata (SNr) and entopeduncular nucleus (direct striato-
nigral pathway), while MSNs expressing dopamine D2-receptors
(D2Rs) and enkephalin, project to the lateral part of the globus
pallidus (LGP) (indirect striatopallidal pathway) [5–7]. These two
subpopulations are homogenously distributed throughout the
striatum, and are known to have opposite behavioral effects, as
they are coupled to output pathways with opposing properties [8].
However, the exact degree of segregation between these two types
of MSNs has been much disputed.
The recent introduction of drd1a-EGFP and drd2-EGFP bacterial
artificial chromosome (BAC) transgenic mice, in which striatonigral
and striatopallidal neurons are specifically labeled [9], allowed the
demonstration that subpopulations of MSNs display very distinct
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expressing tagged DARPP-32 [18] or Cre [19] in the two
populations allow further study of each cell population, and the
use of other promoters [20] or different fluorescent reporters [21]
provides additional powerful tools. However, the only previous study
which examined whether all the MSNs express either D1R or D2R,
concluded that an important fraction of MSNs (39–50%) did not
express fluorescent proteins in BAC transgenic mice with drd1a and
drd2 promoters [21]. These results could be due to a failure to detect
neurons with low expression levels of fluorescent protein. Alterna-
tively, they could indicate the existence of a population of MSNs
expressing neither D1R nor D2R. At any rate, such results cast
doubt on the generality of the conclusions of all the above studies.
Therefore, we undertook a study to unquestionably clarify the
pattern of expression of EGFP under the control of D1R and D2R
promoters in MSNs. By using a variety of markers, we validate a
simple method for identifying MSNs and other striatal neurons,
based ontheirnuclearmorphology.Wethen showthat all MSNsare
labeled in double drd1a- and drd2-EGFP transgenic mice and that
only neurons expressing D1R project to the SNr.
Materials and Methods
Animals
A total of 17 animals were used in this study. Four C57Bl/6J
WT mice were used for characterization of nuclear morphology of
striatal neurons and quantification of nuclei. Six C57Bl/6J–Swiss
Webster hybrid transgenic mice carrying BAC that express
enhanced green fluorescent protein (BAC-EGFP) under the
control of D1R promoter (drd1a-EGFP) or D2R promoter (drd2-
EGFP) were used for characterization of striatonigral and
striatopallidal specificity of labeling. Two drd1a-EGFP and two
drd2-EGFP Swiss-Webster mice were used for assessment of
fluorescence intensity. Three drd1a-EGFP/drd2-EGFP double
transgenic mice, each from a different crossing of drd1a-EGFP
and drd2-EGFP homozygous mice, were used for quantification of
fluorescent neurons. BAC-EGFP mice were originally generated
by the GENSAT (Gene Expression Nervous System Atlas)
program at the Rockefeller University (New York, NY) [9]. All
animals were male 7- to 8-week old mice, and they were
maintained in a 12 h light/dark cycle, in stable conditions of
temperature (22uC) and humidity (60%), with food and water ad
libitum. All experiments were in accordance with the guidelines of
the French Agriculture and Forestry Ministry for handling animals
(decree 87849, license B75-05-22).
Retrograde tracing of striatonigral neurons
Striatonigral neurons were retrogradely labeled by unilateral
injections of FluoroGold (Interchim, Montluc ¸on, France) into the
substantia nigra pars reticulata of drd1a- and drd2-EGFP mice
(anteriority from bregma (mm): 23.3; laterality: 1.3, depth from
cortical surface: 24.5). Animals were anaesthetized with sodium
pentobarbital (60 mg/kg, i.p., Sanofi-Aventis, France), and
FluoroGold (2% dissolved in 0.9% weight/vol NaCl) was injected
unilaterally using a glass micropipette (tip diameter 30 mm).
FluoroGold was ejected microiontophoretically by applying
positive current pulses of 5 mA (5 s on/5 s off) for 20 min.
Overlying skin was sutured and mice were returned to their home
cages after recovery from anesthesia. Seven days after injection,
animals were perfused as indicated below.
Tissue preparation
Mice were injected with pentobarbital (500 mg/kg, i.p., Sanofi-
Aventis, France) and transcardially perfused with 4% (weight/vol.)
paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.5).
Brains were post-fixed overnight in the same solution and stored at
4uC. Thirty-mm thick sections were cut with a vibratome (Leica,
France) and stored at 220uC in a solution containing 30% (vol/
vol) ethylene glycol, 30% (vol/vol) glycerol and 0.1 M sodium
phosphate buffer, until they were processed for immunofluores-
cence. Brain regions were identified using a mouse brain atlas
[22], and sections equivalent to bregma 1.18 mm (medial nucleus
accumbens, dorsal striatum) and 23.16 mm (substantia nigra)
were taken. Sections were processed for immunofluorescence as
described below.
Immunofluorescence
Day 1: free-floating sections were rinsed in Tris-buffered saline
(TBS; 0.25 M Tris and 0.5 M NaCl, pH 7.5), incubated for 5 min
in TBS containing 3% H2O2 and 10% methanol, and then rinsed
three times for 10 min each in TBS. After 15 min incubation in
0.2% Triton X-100 in TBS, sections were rinsed three times in
TBS again. Finally, they were incubated overnight at 4uC with the
various primary antibodies. Rabbit polyclonal antibodies against
fibrillarin (1:1000, Abcam) were used as nucleolar marker. For the
identification of each type of striatal neuron, monoclonal
antibodies against DARPP-32 (1:1000, gift from Paul Greengard)
were used, as well as rabbit polyclonal antibodies against
parvalbumin (1:2000, Swant), calretinin (1:2000, Swant) and
choline acetyltransferase (1:2000, Chemicon International). Rat
polyclonal antibodies against somatostatin (1:2000, Millipore
Corporation) were also used. FluoroGold retrogradely marked
neurons were identified using a rabbit polyclonal antibody
(1:10 000, Millipore, Molsheim, France).
Day 2: sections were rinsed three times for 10 min in TBS and
incubated for 45 minutes with goat-anti mouse Alexa488-conju-
gated (1:400, Molecular Probes), goat-anti mouse, rabbit or rat
Cy3-coupled (1:400, Jackson Lab) and/or goat-anti mouse or
rabbit Cy5-coupled (1:400, Jackson Lab) secondary antibodies.
Sections were rinsed for 10 min twice in TBS. Eventually nuclei
were counterstained by incubating for 5 min with 1 mM TO-
PRO-3 iodide (Molecular Probes) diluted on TBS. Finally, sections
were rinsed twice in TB (0.25 M Tris) and mounted in Vectashield
Mounting Medium (Vector laboratories).
Analysis of fluorescence
Confocal microscopy and image analysis were carried out at the
Institut du Fer a ` Moulin Imaging Facility. Double- and triple-labeled
images were obtained bilaterally using sequential laser scanning
confocal microscopy (SP2, Leica). EGFP-labeled neurons were
visualized by direct detection of endogenous fluorescence. To
compare fluorescence intensity in the various transgenic strains,
EGFP was recorded at three photodetection voltages (621.3v,
727.4v and 641.0v). EGFP intensity values were determined using
Leica LCS software by a black-to-yellow color look-up table
(LUT), in which absolute black is represented in green (RGB=0)
and absolute white is represented in blue (RGB=255).
Nuclear and cellular quantification
Classification of TO-PRO-3 stained nuclei. Sections
immunolabeled with various neuronal markers were counterstained
with TO-PRO-3, a double-stranded DNA intercalating fluorescent
molecule, commonly used for laser confocal microscopy analysis
[23,24]. Five different categories of nuclei (A–E) were defined
according to three criteria: maximum nuclear diameter, nuclear
shape and heterochromatin distribution (Table 1). Using Leica LCS
software, maximum nuclear diameter was defined as the longest line
that crossed the nucleus. Nuclear shape was fixed by drawing the
Striatal MSNs & BAC-EGFP Mice
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distribution was defined regarding nuclear localization and number
of densely packed regions of chromatin, highly stained with TO-
PRO-3.
Validation of nuclear morphology as a marker for
neuronal subtype. A total of 45 images of TO-PRO-3
stained nuclei from striatal neurons (9 for each neuronal type)
were analyzed. They were mixed, randomly named and 4
unaware observers classified them into the five established
categories according to criteria (A–E). Neuronal identity was
then disclosed and the proportion of correct identification was
determined for each category.
Proportion of MSNs in the striatum. The total number of
cells (neuronal and non-neuronal) in striatal sections from C57Bl/
6J WT mice was assessed by counting TO-PRO-3 labeled nuclei.
The total number of neurons was determined by calculating the
percentage of TO-PRO-3-labeled cells that were immunoreactive
for the neuronal marker NeuN. The same quantification was done
for DARPP-32-immunoreactive neurons and the percentage of
TO-PRO-3-labeled cells that were DARPP-32-positive neurons
was calculated. Next, the percentage of neurons in each nuclear
staining category (A–E or X, as described above), was calculated
with respect to the total number of TO-PRO-3 labeled nuclei.
Finally, the percentages of neurons for each category were
determined among DARPP-32-positive neurons.
EGFP-labeled cells in BAC-transgenic mice. All EGFP-
expressing neurons were counted in 5–6 images per striatal region
and classified as low-EGFP (only visible above 727.4v) and high-
EGFP (detectable at 621.3v). Next, all DARPP-32-
immunoreactive neurons were counted. Red and green images
were then combined, and the percentages of neurons within the
following categories were assessed: EGFP-negative / DARPP-32-
positive; EGFP-positive / DARPP-32-positive; low-EGFP /
DARPP-32-positive; high-EGFP / DARPP-32-positive neurons.
Results
Striatal neuronal populations display distinct nuclear
morphology
Since the aim of this study was the precise quantification of
neuronal populations in the striatum we first used TO-PRO-3, a
fluorescent probe which labels DNA, to identify all cell nuclei. We
noticed that nuclear staining with TO-PRO-3 was heterogeneous
in mouse striatal sections, as in other brain regions, and we
investigated whether this heterogeneity matched with known
cellular types. We first characterized the staining pattern of TO-
PRO-3 in cells labeled with DARPP-32, a regulatory protein
found in cytoplasm and nuclei of MSNs [25,26]. In addition to a
diffuse weak and heterogeneous nuclear staining, several areas of
very intense TO-PRO-3 labeling were clearly apparent within the
nucleus (Fig. 1, arrows). These areas, presumably corresponding to
heterochromatin, did not overlap with nucleoli, identified by
fibrillarin immunofluorescence (Fig. 1, arrowheads), but were
adjacent to them. Interestingly, both intensely TO-PRO-3-labeled
areas and fibrillarin-positive areas coincided with virtually absent
DARPP-32 immunoreactivity (Fig. 1).
To determine whether we could distinguish neurons and non-
neuronal cells on the basis of their nuclear morphology, we used
antibodies for NeuN, a general neuronal marker [27]. NeuN-
negative nuclei, presumably from glial cells, could easily be
differentiated from those of neurons by virtue of the intense and
compact TO-PRO-3 staining of the entire nucleus (Fig. 2).
We then undertook a systematic study of TO-PRO-3 labeling of
the striatal neuronal populations. We doubly labeled cells with
Table 1. Nuclear morphology of striatal neurons.




DARPP-32 A 10–11 mm Rounded $3 scattered clumps, sharp nuclear limit with thin
discontinuous peripheral line
Parvalbumin B 9–11 mm Slightly elongated 1–2 central clumps
Calretinin C 6–10 mm Irregular rounded 1 central clump
Somatostatin D 8–12 mm Elliptic (axis ratio $1.5) 1 central clump
ChAT E 10–13 mm Irregular Irregular staining with one or more clumps of various
sizes
1Nuclear diameter is defined as the longest line that can cross the nucleus.
2Nuclear shape is fixed by drawing the outline of the nucleus.
3Refers to regions of intense TO-PRO-3 staining (clumps). The rest of the nucleus contains light staining.
doi:10.1371/journal.pone.0004770.t001
Figure 1. DARPP-32-positive striatal neurons have characteristic nuclear TO-PRO-3 staining. Confocal image of a striatal neuron triply
stained with antibodies for DARPP-32 (green, 1), the nuclear marker TO-PRO-3 (blue, 2) and antibodies for the nucleolar protein fibrillarin (red, 3).
Compact chromatin intensely stained with TO-PRO-3 (arrows) is located at the vicinity of nucleoli (arrowheads), but does not overlap with fibrillarin
immunoreactivity. Scale bar: 5 mm.
doi:10.1371/journal.pone.0004770.g001
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neuronal subtypes: DARPP-32 for MSNs [28], choline acetyl-
transferase (ChAT) for cholinergic interneurons, and parvalbumin,
calretinin, and somatostatin for GABAergic interneurons [4]
(Fig. 3). Interestingly, nuclear diameter and shape, as well as TO-
PRO-3 staining appeared to be different for each neuronal type
(Fig. 3). DARPP-32-positive neurons contained rounded nuclei
with a 10–11-mm diameter, characterized by the presence of 3–4
clumps of compact chromatin intensely stained with TO-PRO-3
and a thin discontinuous lining of TO-PRO-3 staining at the
periphery of the nucleus, providing a sharp boundary (Fig. 1, 3A).
GABAergic interneurons expressing parvalbumin had elongated
nuclei with a diameter of 9 to 11 mm, in which areas of intense
TO-PRO-3 labeling formed 1 or 2 clumps in the vicinity of what
was likely to be the nucleolus (Fig. 3B). Calretinin-positive cells
were characterized by their small size (6–10 mm) and the fact that
TO-PRO-3 labeled heterochromatin was typically concentrated as
a unique cluster in the central part of the nucleus (Fig. 3C).
Somatostatin-containing interneurons also displayed small nuclei
with heterochromatin located in a single central clump, but could
be distinguished from the other types of interneurons by their
elongated nuclei (axis ratio $1.5), in agreement with previous
studies in which the fusiform perikarya of somatostatin-positive
neurons was defined as a typical morphological characteristic [29]
(Fig. 3D). Finally, nuclei of cholinergic interneurons were easily
distinguishable from the other striatal neurons by virtue of their
large size (about 12 mm, Fig. 3E). TO-PRO-3 staining was
irregular with one or more clumps of various sizes.
Nuclear morphology is a good marker for striatal
neuronal types
Since TO-PRO-3 nuclear staining nuclei appeared to be
systematically different among striatal neuronal subtypes, we
tested whether it could be sufficient for their identification. To do
so, we used criteria based on the nuclear appearance of each of the
five types of striatal neurons (Table 1). We assessed the capacity of
four unaware observers to identify striatal neurons on the basis of
their nuclear morphology after TO-PRO-3 staining (Fig. S1). The
percentage of correct identification of MSNs, and calretinin- or
ChAT-positive interneurons was 90% or higher (Fig. S1).
Parvalbumin- and somatostatin-positive neurons were correctly
identified in 80% and 70% of the cases, respectively (Fig. S1). The
parvalbumin-positive neurons were easily identified when they had
2 chromatin clumps, and the somatostatin-positive neurons when
their elongated shape was apparent, i.e. when the section plane
was sufficiently parallel to the longest axis. However, these
conditions were not always satisfied. Altogether, our results show
that nuclear morphology allows the identification of MSNs with a
high success rate and is a good marker for interneuron subtypes.
Identification of MSNs based on DARPP-32
immunoreactivity and nuclear morphology
We used the tools validated above to accurately estimate the
proportion of MSNs in the striatum, taking into account both
DARPP-32 immunoreactivity and nuclear morphology. We
determined the total number of cells in striatal sections by double
staining with the pan-neuronal marker NeuN and TO-PRO-3
(Fig. 4A), or with DARPP-32 and TO-PRO-3 (Fig. 4B). We then
counted for each double staining the number of cells identified by
their TO-PRO-3-stained nuclei that were NeuN-positive or
DARPP-32-positive (Fig. 4C). In parallel we counted the number
of neurons in categories A–E defined in Table 1. The percentage
of NeuN positive cells was 7060.4% in the dorsal striatum,
8061.4% in the core of the nucleus accumbens (NAc), and
7563.1% in the shell (means6SEM, 3 mice) (Fig. 4C). DARPP-
32-positive neurons accounted for 6862.3% of the cells in dorsal
striatum, 7861.4% in NAc core and 7362% in NAc shell (Fig. 4C)
(means6SEM, 3 mice). Thus, as expected, DARPP-32-positive
neurons formed the largest population of striatal neurons (i.e.
about 97% of the neurons in the 3 striatal regions). Similar results
were obtained when classification of all nuclei was done following
the five categories described previously (Fig. 4C). Note that the
percentages of cells in category A was consistently slightly lower
than those obtained with DARPP-32 immunolabeling because
identification on the basis of nuclear morphology required a
section in which the nucleus was well visible and its features
identifiable, which was not the case in all DARPP-32-positive cells.
However, it should be pointed out that when the nucleus of
DARPP-32-positive cells was clearly visible it always had the
typical morphology described in Fig. 3A. All nuclei classified in
Figure 2. Neuronal and non-neuronal striatal cells can be distinguished by their nuclear staining. Confocal section of a striatal slice
doubly stained with the pan-neuronal marker NeuN (red) and the nuclear marker TO-PRO-3 (blue). Nuclei from non-neuronal celIs are small, compact,
and diffusely and intensely stained with TO-PRO-3. In contrast, NeuN-positive cells (neurons) have bigger nuclei, with diffuse irregular light TO-PRO-3
staining containing clumps of intense fluorescence. Scale bar: 20 mm. Insets on the right panels are four examples (1–4) of nuclear morphology of
non-neuronal cells. Scale bar: 5 mm.
doi:10.1371/journal.pone.0004770.g002
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virtually no DARPP-32-positive neuron was misclassified into
the other categories (161%). Nuclei classified in categories B–E
constituted approximately 5% of the total. These results combined
with our previous observation that DARPP-32-positive neurons
are not labeled with markers for striatal interneurons [13]
demonstrate that DARPP-32 antibodies label all MSNs and only
MSNs in the striatum.
EGFP expression driven by the drd1a and drd2 promoters
labels all MSNs in BAC-EGFP transgenic mice
Since we had validated tools to accurately and exhaustively
identify striatal MSNs, we assessed the exact proportions of
DARPP-32-positive MSNs expressing the dopamine D1R and
those expressing the D2R. For this purpose we used two strains of
BAC transgenic mice (drd1a-EGFP and drd2-EGFP) [9] which
have been extensively studied [10–17]. When we compared the
Figure 3. The various striatal neuronal populations have distinct nuclear morphology. Mouse striatal slices were labeled with various
markers specific for each type of striatal neuron and analyzed by confocal microscopy. For each row, the left panel shows a double staining with an
antibody specific for a neuronal subtype and TO-PRO-3 (scale bar: 25 mm), the right panels are high magnification of TO-PRO-3-stained neurons (scale
bar: 5 mm). For the first high magnification picture, which corresponds to the boxed area in the left panel, the dashed line follows the nuclear
envelope and the number of clumps of highly compacted chromatin is indicated. (A) Neurons positive for DARPP-32, a marker of medium-sized spiny
neurons, have a rounded nucleus about 10–11 mm of diameter with $3 clumps of intense TO-PRO-3 staining. (B–D) GABAergic interneurons. (B)
Parvalbumin-positive interneurons have slightly elongated nuclei of 9–11 mm of diameter. Chromatin clumps are frequently observed surrounding
the nucleolus, forming 1 or 2 clusters. (C) Nuclei of calretinin-positive interneurons are small (6–10 mm), irregular but mostly circular and have a
unique central clump of heterochromatin. (D) Somatostatin-positive interneurons often have elongated nuclei (longest axis 8–12 mm, axis ratio $1.5)
with a central clump of dense chromatin. (E) Cholinergic interneurons, identified by choline acetyltransferase (ChAT) immunoreactivity, have the
largest nuclei (10–13 mm) with diffuse and irregular TO-PRO-3 staining with small clumps of intense fluorescence.
doi:10.1371/journal.pone.0004770.g003
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that it was always weaker in drd1a-EGFP mice than in drd2-EGFP
mice. Photodetection of EGFP at a low voltage did not allow a
correct visualization of striatal D1R neurons in drd1a-EGFP
animals (Fig. S2A1, 19), while it was sufficient for identifying D2R
neurons in drd2-EGFP mice (Fig. S2A2, 29). A high photodetection
voltage permitted a correct identification of EGFP neurons in
drd1a-EGFP mice (Fig. S2B1, 19), whereas it generated a saturated
signal for D2R neurons in drd2-EGFP mice (Fig. S2B2, 29). This
marked difference in fluorescence intensity between drd1a-EGFP
and drd2-EGFP strains was observed in all mice analyzed and
presumably reflected differences in EGFP expression levels. We
then crossed the two transgenic lines and studied the F1 progeny,
which was hemizygous for both BAC transgenes. Analysis of
striata of drd1a-EGFP/drd2-EGFP mice at a medium photodetec-
tion voltage, sufficient to visualize all neurons in drd1a-EGFP mice,
showed a clear distinction between weakly labeled neurons (Fig.
S2C1, 19), which were likely to correspond to D1R-expressing
neurons, and intensely labeled neurons (Fig. S2C2, 29), which were
likely to correspond to neurons expressing D2R or both receptors.
We have previously reported that EGFP is detected only in
DARPP-32-positive neurons in the striatum of drd1a-EGFP mice,
while in drd2-EGFP mice it is detected in DARPP-32-positive and
in a few DARPP-32-negative and ChAT-positive neurons [13].
However, our previous study did not determine whether all
DARPP-32-positive cells expressed EGFP under the control of
either drd1a or drd2 promoter. In fact a recent report [21]
concluded that a relatively large proportion of striatal neurons
(39–50%) do not express EGFP in double transgenic BAC lines.
To address this issue we performed a triple fluorescence analysis
combining EGFP fluorescence with DARPP-32 and ChAT
immunofluorescence in drd1a-EGFP/drd2-EGFP double transgen-
ic mice (Fig. 5A, B). The majority of weakly EGFP-labeled
neurons were identified as MSNs (Fig. 5A, B, type 1), as well as the
totality of intense EGFP neurons (Fig. 5A, B, type 2), as revealed
by their DARPP-32 immunoreactivity. The small proportion of
weak EGFP neurons that were negative for DARPP-32 were
always identified as cholinergic interneurons, as shown by
colabeling for ChAT (Fig. 5A, B, type 3) [30].
We next examined the proportion of striatal MSNs which
expressed EGFP in the striatum of drd1a-EGFP/drd2-EGFP
double transgenic mice, by calculating the percentage of
DARPP-32-positive cells that showed EGFP fluorescence. As
shown in Fig. 5C–E, this percentage was always 100% in the
various regions of the striatum (Total EGFP bar). The same results
were obtained when MSNs were identified only on the basis of
their nuclear morphology (data not shown). We were simply
unable to find any DARPP-32-immunoreactive neuron which
lacked EGFP fluorescence. These results clearly demonstrate that
all striatal MSNs express either drd1a-EGFP or drd2-EGFP, or
both, in double transgenic mice, in sharp contrast to what has
been reported recently [21].
Figure 4. Proportion of DARPP-32-positive cells in the striatum. Low-magnification confocal section of a mouse striatal slice doubly stained
with NeuN antibodies (red) and TO-PRO-3 (blue) (A), or with DARPP-32 antibodies (green) and TO-PRO-3 (blue) (B). Scale bars: 25 mm. (C) Bar graphs
representing the proportion of cells identified as neurons by NeuN immunoreactivity (NeuN+), of DARPP-32-immunoreactive neurons (DARPP-32+)
and of nuclei classified into A or B–E categories. The total number of cells (neuronal and non-neuronal) was determined by nuclear staining with TO-
PRO-3 (TP3) in mouse dorsal striatum (DStr) and nucleus accumbens core (Core) and shell (Shell). The small percentage of cells classified in B–E
categories, corresponds to striatal interneurons. Data are means6SEM; n=3 mice; 2908 (NeuN count), 2091 (DARPP-32 count) and 1517 (nuclei
categories count) cells counted.
doi:10.1371/journal.pone.0004770.g004
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active neurons that showed a weak EGFP intensity (Fig. 5C–E,
Low EGFP bar graphs) and those showing a strong EGFP intensity
(Fig. 5C–E, High EGFP bar graphs). In the dorsal striatum and
NAc core, the proportion of weakly labeled neurons and intensely
labeled neurons was similar (about 51 and 49% respectively,
Figs. 5C,D). In the NAc shell, a slightly higher percentage of
intensely labeled neurons was observed (about 53%, Fig. 5E). It is
important to note that weakly labeled neurons corresponded to
D1R-expressing neurons, whereas intensely labeled neurons could
correspond to neurons expressing either D2R alone or both D1R
and D2R. If we take this into consideration, the numbers obtained
here are similar to the proportions obtained in a previous study
[13], in which populations were estimated from separate drd1a-
EGFP and drd2-EGFP mice.
Striatonigral neurons are virtually exclusively D1R-
expressing neurons
Previous reports with BAC transgenic mice have shown that
striatonigral neurons are essentially D1R-expressing neurons
[12,13,19]. Because the present study lifted the uncertainty about
the existence of non-EGFP-expressing MSNs in the BAC
transgenic mice, we used these mice to reassess the nature of
striatonigral neurons by retrograde labeling. FluoroGold, a
retrograde tracer, was stereotactically injected in the SNr of
drd1a-EGFP and drd2-EGFP mice. FluoroGold-immunoreactive
neurons were detected in the striatum ipsilaterally to the injection
side, but not on the contralateral side (Fig. 6A). In drd1a-EGFP
mice, 10060% of FluoroGold-positive neurons were labeled with
EGFP, indicating that all striatonigral neurons express the D1R
(298 neurons examined from two different mice, Fig. 6A). In drd2-
EGFP mice, 99.360.6% of FluoroGold-immunoreactive neurons
did not contain EGFP (566 neurons examined from 2 different
mice, Fig. 6B). Thus only 4 out of 566 retrograde-labeled neurons
(0.7%) expressed EGFP in drd2-EGFP neurons. Since in drd1a-
EGFP mice FluoroGold was completely colocalized with EGFP,
these results suggest that the few neurons which contained both
EGFP and FluoroGold in drd2-EGFP mice expressed both D1 and
D2 receptors. As expected, immunolabeling with DARPP-32
showed that both EGFP-neurons and FluoroGold-neurons were
MSNs (Fig. 6B). Interestingly, detailed analysis of the LGP of
drd1a-EGFP mice revealed a loose weave of intermingled fibers
Figure 5. All MSNs express EGFP in drd1a-EGFP/drd2-EGFP double transgenic mice. (A, B) Striatal slices from drd1a-EGFP/drd2-EGFP mice
were studied by triple labeling for DARPP-32 immunoreactivity (red), ChAT immunoreactivity (blue) and EGFP autofluorescence (green). EGFP
fluorescence was classified as high or low (see Fig. S2). Note that all high-EGFP neurons are MSNs, since they are always colabeled for DARPP-32,
whereas low-EGFP neurons can be either MSNs (labeled for DARPP-32) or cholinergic interneurons (labeled for ChAT). Neurons could be therefore
classified into three categories: 1, low EGFP/DARPP-32-positive (D1R-expressing MSNs); 2, high-EGFP/DARPP-32 positive (D2R-expressing MSNs,
possibly coexpressing D1R); and 3, low EGFP/DARPP-32-negative (cholinergic interneurons expressing D2R). (B) Higher magnification showing
neurons in the three categories defined above. Images are single confocal sections. Scale bars: 40 mm (A), 10 mm (B). (C–E) The percentage of DARPP-
32-immunoreactive neurons showing any (Total EGFP), low (Low-EGFP) or high (High-EGFP) EGFP fluorescence in the dorsal striatum (DStr, C),
nucleus accumbens core (Core, D) and shell (Shell, E). All EGFP neurons that do not show DARPP-32 immunoreactivity were identified as cholinergic
interneurons. Data are means6SEM; n=3 mice; 967 (C), 1708 (D) and 1271 (E) cells counted.
doi:10.1371/journal.pone.0004770.g005
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targeting the pallidum (Fig. 7), in agreement with the basal
fluorescent signal previously observed in the LGP of drd1a-EGFP
mice [12,13]. Such fibers might account for the few branched
neurons projecting to both SNr and GP reported in rats [31,32].
Discussion
In the present study we show that nuclear staining with TO-
PRO-3 provides a simple means for the identification of striatal
neuronal populations in the absence of other markers. Appearance
of chromatin is often casually used on electron micrographs to
identify neuronal populations, but, to our knowledge, nuclear
staining has not been exploited for systematic identification of
striatal neurons. Comparison with DARPP-32 immunoreactivity,
a well-established marker for MSNs [25,28,33], showed that these
neurons have a distinct nuclear appearance following DNA
staining, in comparison to other striatal cells. This appearance is
sufficiently characteristic to allow their accurate identification.
Other striatal neurons also have distinct nuclear staining patterns,
which allow a good prediction of their nature. This simple method
may be useful to identify striatal neurons in tissue sections and
potentially in living tissue, using vital DNA fluorescent dyes. Since
the intensity of TO-PRO-3 fluorescence reflects DNA concentra-
tion [34,35], the intensely labeled areas presumably correspond to
heterochromatin, which is more condensed than euchromatin.
Thus, it is interesting to note that various neuronal types have
distinct nuclear organizations, likely to reflect distinct different
functional states [36,37]. The relatively low abundance of
condensed heterochromatin, reduced to 3–5 small clumps in
MSNs may suggest that a larger repertoire of genes is accessible to
transcription in these neurons than in other cell types. Similar
nuclear appearances were observed for principal neurons in other
brain regions such as pyramidal neurons of the cerebral cortex
(data not shown). However, further studies are necessary to
determine whether nuclear staining can be used for reliably
identifying cell populations outside of the striatum, as we could
predict.
Although it is clear that most striatal neurons are MSNs which
project to the SNr or the LGP and express distinct proteins, the
degree of segregation of these two populations has been intensely
debated. Many studies in the last 20 years have attempted to
quantify the proportion of MSNs expressing D1R, D2R or both by
using various approaches [7,38–40]. Converging evidence showed
that striatonigral neurons express preferentially D1R [41,42],
dynorphin [38], and substance P [43–45], whereas striatopallidal
neurons express preferentially D2R [46], enkephalin [38,47], and
A2A receptors [48,49]. However, some results have suggested the
existence of a fairly high degree of overlap between the expression
of D1R and D2R [32]. The recent introduction of drd1a-EGFP
and drd2-EGFP BAC transgenic mice allows an easy identification
of D1R-expressing and D2R-expressing neurons [9,12,19]. The
use of markers of various types of striatal neurons showed that
EGFP was expressed in striatonigral MSNs of drd1a-EGFP mice,
whereas striatopallidal MSNs and cholinergic interneurons were
labeled in drd2-EGFP mice [11,13]. These studies showed that
approximately half of the MSNs were labeled with either probe,
but they did not assess whether all the MSNs expressed one or the
other. This information is critical, however, to estimate the
number of MSNs expressing both receptors. Such measurement
requires the expression of markers for D1R and D2R in the same
animal. A recent paper elegantly addressed this question by using
the drd1a promoter to drive the expression of tdTomato, a red
fluorescent protein, in BAC transgenic mice [21]. However, when
these authors crossed drd1a-tdTomato and drd2-EGFP mice, they
estimated that up to 39% of MSNs did not express either
Figure 6. All striatonigral projection neurons express EGFP under the control of drd1a promoter. (A) Retrograde labeling of striatonigral
neurons in drd1a-EGFP mice after unilateral FluoroGold injection in the substantia nigra pars reticulata (SNr). FluoroGold immunoreactivity (red) in the
SNr (scale bar: 200 mm; insets: 46magnification) and the dorsal striatum (DStr) of drd1a-EGFP mice in the hemisphere ipsilateral (injected side) or
controlateral (non-injected side) to the injection site. In the injected side FluoroGold-immunoreactive neurons always contained EGFP fluorescence
(i.e. expressed D1R). No FluoroGold-positive neurons were observed in the non-injected side. Scale bars: 40 mm. (B) The same experiment was carried
out in drd2-EGFP mice. EGFP fluorescence (1) was detected together with FluoroGold immunoreactivity (2) and DARPP-32 immunoreactivity (3), in the
DStr and NAc core (Core) and shell (Shell). FluoroGold-immunoreactive neurons did not contain EGFP in all striatal regions (Merge 1+2). All EGFP and
FluoroGold-positive neurons were DARPP-32-immunoreactive MSNs (Merge 1+2+3). Images are single confocal sections. Scale bar: 40 mm.
doi:10.1371/journal.pone.0004770.g006
Figure 7. EGFP containing fibers in the lateral globus pallidus
of drd1a-EGFP and drd2-EGFP mice. EGFP fluorescence was
determined at low (A, B) and high (A inset and C) magnification in
the LGP of drd1a-EGFP (A and C) and drd2-EGFP (B) mice. Scale bars:
40 mm. Inset: 46 stacked image. FB: fiber bundles presumably
corresponding to striatonigral axons crossing the LGP in drd1a-EGFP
mice. Note that outside of these bundles, a loose weave of intermingled
fibers is spread across the LGP in drd1a-EGFP mice, possibly
corresponding to sparse terminals, which are much less intense than
those observed in drd2-EGFP mice.
doi:10.1371/journal.pone.0004770.g007
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unlabeled neurons was even higher (50%) when they crossed
drd1a-EGFP and drd2-EGFP mice. These results implied that
either the fluorescent protein expression was too low to be detected
in a large proportion of the neurons for some technical reason, or
that a substantial number of MSNs did not express D1R or D2R.
In any case, they casted doubt on the generality of the results
obtained in BAC transgenic mice. They also implied that it was
impossible to use the lack of expression of a marker as a means to
identify a neuronal population. In light of our results, it appears
that a major limitation of the study of Shuen et al. [21] was that the
identification of neuronal populations in the striatum and
distinction between neurons and glia was not convincingly done.
In addition it is possible that some weakly fluorescent drd1a-EGFP
expressing neurons were overlooked. Therefore the reported
estimates may have been inaccurate. In the present study we
carefully quantified striatal neuronal populations, using antibodies
for NeuN, DARPP-32, various interneuron markers and nuclear
staining patterns. We obtained convergent results with these
various approaches which clearly showed that all MSNs expressed
either D1R or D2R or both.
It is interesting to compare the quantifications of neurons
carried out by various techniques. DARPP-32 antibodies were
reported to label 96.4% of medium-sized neurons of the rat
striatum (cell bodies 10–15 mm) [28]. In complete agreement
with these results, we find that about 97% of neurons (NeuN-
positive cells) were DARPP-32 positive. In our previous study
[13] we estimated that 52% of the MSNs in the dorsal striatum,
53% in the NAc core and 47% in the shell expressed only D1R.
These numbers are very similar to those obtained in the present
study (51.1%, 51.4%, and 46.9%, respectively). Moreover, the
demonstration that all MSNs express one or the other dopamine
receptor allows us to conclude that the numbers previously
calculated to estimate the proportion of neurons expressing both
types of receptors (5%, 6%, and 17%, in the dorsal striatum,
core, and shell, respectively, [13]) are not underestimations but
are likely to reflect the real proportions. It should be kept in
mind, however, that all these numbers are based on the
expression of a reporter protein, EGFP, and not of receptors
themselves.
Although striatonigral and striatopallidal pathways are
distinct and mostly formed by different MSNs [38], anatomical
and electrophysiological studies suggest the existence in rat and
monkey of neurons which project to both SNr and GP [31,32].
Having demonstrated that all MSNs express D1R or/and D2R,
we used a retrograde neuronal tracer locally injected into the
SNr to determine which population of neurons projected to the
SNr. As expected, we found that all retrogradely labeled
striatonigral neurons were EGFP-positive in drd1a-EGFP mice,
whereas only very few (,1%) retrogradely labeled neurons
expressed EGFP in drd2-EGFP mice. These observations
demonstrate that striatonigral neurons all express D1R and
that only a very tiny fraction may also express D2R. On the
other hand, observations in our and other laboratories support
the existence of a small fraction of D1R-neuron projections to
the pallidum, since weak but noticeable staining is present in the
LGP of drd1a-Cre, chrm4-EGFP and drd1a-EGFP mice
[12,13,19]. Since striatonigral fibers cross the pallidum, it
would be difficult to completely rule out the artefactual labeling
of some of these fibers using retrograde staining. However,
analysis of the LGP of drd1a-EGFP mice revealed a light
interlace of fibers that could account for sparse terminals of
striatonigral neurons in the pallidum. Such fibers might account
for the few branched neurons projecting to both SNr and GP
reported in rats [31,32]. In contrast, our findings clearly show
that the overwhelming majority of D2R-expressing neurons do
not project to the SNr, in agreement with previous reports
[31,38].
The present study provides evidence that a simple nuclear
staining method can be sufficient to identify MSNs, and also to
recognize the various striatal interneurons with a good predictive
value. The precise analysis of BAC transgenic mouse lines shows
that 100% of the MSNs express D1R or D2R or in a minority of
cases both. This shows that the use of a single transgenic line in
combination with DARPP-32 staining or a nuclear marker is
sufficient for the correct distinction of striatonigral and striato-
pallidal neurons in histological analysis.
Supporting Information
Figure S1 Identification of striatal neurons based on their
nuclear morphology. Images of TO-PRO-3-stained nuclei from 9
neurons of each striatal neural population identified with specific
antibodies as in Fig. 3, were randomly numbered and mixed. The
pictures were examined by four observers unaware of the identity
of the neurons, who classified them into 5 categories according to
the criteria of Table 1. Bars represent the means6SEM of correct
identifications for each category.
Found at: doi:10.1371/journal.pone.0004770.s001 (0.24 MB TIF)
Figure S2 Different levels of striatal EGFP fluorescence in
drd1a-, drd2- and drd1a-EGFP/drd2- EGFP transgenic mice. (A–
C) Confocal microscopy analysis at different photodetection
voltages in striatal slices of drd1a-EGFP (A1, B1), drd2-EGFP
(A2, B2) and drd1a-EGFP/drd2-EGFP mice (C). (A) At a low
photomultiplier tube (PMT) voltage (621.3v), EGFP fluorescence
appears weak in drd1a-EGFP mice, and striatal D1R neurons
barely visualized (1). The same PMT voltage is sufficient for
correct visualization of striatal D2R neurons in drd2-EGFP mice
(2). Note the different degree of saturation of fluorescent neurons
in drd1a-EGFP (19) and drd2-EGFP mice (29), as indicated by the
blue coloring in a black-to-yellow look up table (LUT) color in
each image (right). (B) A higher PMT detection voltage (727.4v)
allows the correct visualization of striatal D1R neurons in drd1a-
EGFP mice (1, 19), whereas D2R neurons of drd2-EGFP mice
appear saturated (2, 29). (C) Striatal slices of drd1a-EGFP/drd2-
EGFP double transgenic mice analyzed at a medium PMT voltage
(641.0v), which allows the distinction of weakly labeled neurons (1,
19) and strongly labeled neurons (2, 29). Low-EGFP neurons are
putative D1R neurons, whereas high-EGFP neurons are putative
D2R neurons. Images are single confocal sections. Scale bars:
40 mm. For all panels the right picture is a 46magnification of the
area indicated in the left picture.
Found at: doi:10.1371/journal.pone.0004770.s002 (7.59 MB TIF)
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